Articles citing this paper
Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy
Jean Spinks A C , Gang Chen B and Lara Donovan A
+ Author Affiliations
- Author Affiliations
A Centre for Health Economics, Monash University, Clayton, Vic. 3800, Australia. Email: lara.donovan@bms.com
B Flinders Health Economics Group, Flinders University, Daw Park, SA 5041, Australia. Email: gang.chen@flinders.edu.au
C Corresponding author. Email: jean.spinks@monash.edu
Australian Health Review 37(5) 675-681 https://doi.org/10.1071/AH13024
Submitted: 7 August 2012 Accepted: 19 August 2013 Published: 28 October 2013
9 articles found in Crossref database.
Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria
Tachkov Konstantin,
Mitkova Zornitsa,
Boyadzieva Vladimira, Petrova Guenka
Pharmaceuticals. 2021 14(1). p.64
The long-term effect of generic price competition on the Hungarian statin market
Répásy Balázs,
Gazsó Tibor,
Elmer Diána,
Pónusz-Kovács Dalma,
Kajos Fanni Luca,
Csákvári Tímea,
Kovács Bettina, Boncz Imre
BMC Health Services Research. 2023 23(1).
Arzneiverordnungs-Report 2019 (2019)
Pathways to ensure universal and affordable access to hepatitis C treatment
Douglass Caitlin H.,
Pedrana Alisa,
Lazarus Jeffrey V.,
‘t Hoen Ellen F. M.,
Hammad Radi,
Leite Ricardo Baptista,
Hill Andrew, Hellard Margaret
BMC Medicine. 2018 16(1).
Patient access to medicines in two countries with similar health systems and differing medicines policies: Implications from a comprehensive literature review
Babar Zaheer- Ud-Din,
Gammie Todd,
Seyfoddin Ali,
Hasan Syed Shahzad, Curley Louise E.
Research in Social and Administrative Pharmacy. 2019 15(3). p.231
Effects of Volume-Price Contracts on Pharmaceutical Prices: A Retrospective Comparative Study of Public Hospitals in Hubei of China
Li Zhuoxian,
Liu Chaojie,
Zuo Keyuan,
Liu Junjie, Tang Yuqing
Frontiers in Pharmacology. 2021 12
Exploring the Evolution of Statin Pricing in Australia: Observations of Price Disclosure Effects on Pharmaceutical Benefits Scheme Expenditure
Lee Leonard, Kim Hansoo
Value in Health Regional Issues. 2024 40 p.27
Impact of price deregulation policy on the affordability of essential medicines for women’s health: a panel data analysis
Liu Junjie,
Wang Liming,
Liu Chenxi, Zhang Xinping
Expert Review of Pharmacoeconomics & Outcomes Research. 2017 17(6). p.625
Challenges for Medicare and universal health care in Australia since 2000
Angeles Mary Rose,
Crosland Paul, Hensher Martin
Medical Journal of Australia. 2023 218(7). p.322
